Skip to main page content

Breaking News: Shaping the future of AMD and DME

Co-Developed Symposium
Co-Developed Symposium | Symposium élaboré conjointement
6:30 AM, Sunday 12 Jun 2022 (1 hour 30 minutes)
Continental Breakfast    07:00 AM to 08:00 AM (1 hour)


At the end of this symposium, participants will be able to:

  • Identify the critical unmet needs in neovascular AMD and DME management
  • Demonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME management
  • Examine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DME
  • Apply new insights from multi-modal imaging platforms to optimize diagnosis and management in the retina clinic

CanMEDS Roles: Medical Expert, Scholar

Varun Chaudhary, MD, Chair
Arif Samad, MD
Sarah Mullen, MD

This symposium was co-developed with the Canadian Ophthalmological Society and Roche, in order to achieve scientific integrity, objectivity and balance.

Scientific Planning Committee Chair - Co-Developed Symposium
Keynote speaker
Keynote Speaker
Scientific Planning Committee - Co-Developed Symposium

Sub Sessions

Talk | Exposé
RetinaCo-Developed Symposium
Panel | Table ronde
RetinaCo-Developed Symposium
Speaker Michael Ip
RetinaCo-Developed Symposium
Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Changes here will affect all session detail pages